Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1
The NM_000022.4(ADA):c.846-1_846delGGinsTT(p.283) variant causes a splice acceptor, splice region, synonymous, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. It is difficult to determine the true allele frequency of this variant because it is of type MNV, and the frequency of such variant types in population databases may be underestimated and unreliable. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. The gene ADA is included in the ClinGen Criteria Specification Registry.
Frequency
Genomes: not found (cov: 32)
Consequence
ADA NM_000022.4 splice_acceptor, splice_region, synonymous, intron
ADA (HGNC:186): (adenosine deaminase) This gene encodes an enzyme that catalyzes the hydrolysis of adenosine to inosine in the purine catabolic pathway. Various mutations have been described for this gene and have been linked to human diseases related to impaired immune function such as severe combined immunodeficiency disease (SCID) which is the result of a deficiency in the ADA enzyme. In ADA-deficient individuals there is a marked depletion of T, B, and NK lymphocytes, and consequently, a lack of both humoral and cellular immunity. Conversely, elevated levels of this enzyme are associated with congenital hemolytic anemia. [provided by RefSeq, Sep 2019]
PKIG (HGNC:9019): (cAMP-dependent protein kinase inhibitor gamma) This gene encodes a member of the protein kinase inhibitor family. Studies of a similar protein in mice suggest that this protein acts as a potent competitive cAMP-dependent protein kinase inhibitor, and is a predominant form of inhibitor in various tissues. The encoded protein may be involved in osteogenesis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, LoF is a know mechanism of disease, Cryptic splice site detected, with MaxEntScore 5, offset of 38, new splice context is: taactactcgctcaacacAGatg. Cryptic site results in frameshift change. If cryptic site found is not functional and variant results in exon loss, it results in frameshift change.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000022.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
Sel.
Gene
Transcript
Tags
HGVSc
HGVSp
Effect
Exon Rank
Protein
UniProt
ADA
NM_000022.4
MANE Select
c.846-1_846delGGinsTT
p.283
splice_acceptor splice_region synonymous intron
N/A
NP_000013.2
ADA
NM_001322051.2
c.774-1_774delGGinsTT
p.259
splice_acceptor splice_region synonymous intron
N/A
NP_001308980.1
F5GWI4
ADA
NM_001322050.2
c.441-1_441delGGinsTT
p.148
splice_acceptor splice_region synonymous intron
N/A
NP_001308979.1
Ensembl Transcripts
Sel.
Gene
Transcript
Tags
HGVSc
HGVSp
Effect
Exon Rank
Protein
UniProt
ADA
ENST00000695956.1
c.-2_-1delGGinsTT
5_prime_UTR
Exon 1 of 3
ENSP00000512285.1
A0A8Q3WKW4
ADA
ENST00000372874.9
TSL:1 MANE Select
c.846-1_846delGGinsTT
p.283
splice_acceptor splice_region synonymous intron
N/A
ENSP00000361965.4
P00813
ADA
ENST00000537820.2
TSL:1
c.774-1_774delGGinsTT
p.259
splice_acceptor splice_region synonymous intron
N/A
ENSP00000441818.1
F5GWI4
Frequencies
GnomAD3 genomes
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.